Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Rythmodan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Some pharmacokinetic parameters of disopyramide in a steady-state situation were studied in 8 patients with arrhythmias. Four… Expand
  • figure I
  • figure 2
2004
2004
SummaryEight healthy male volunteers took a single oral dose of one of the following: Rythmodan (conventionally formulated… Expand
  • figure 2
  • table 1
2004
2004
SummaryThe bioavailability of two slow release preparations of disopyramide has been compared in a randomized cross-over trial of… Expand
  • figure 1
  • table 1
1984
1984
A multi-centre double-blind randomized study is reported in which the effect on mortality of oral disopyramide (300 mg loading… Expand
1984
1984
A Phase I Study was carried out on disopyramide phosphate retard (slow-release) tablets in healthy Japanese subjects, employing… Expand
1980
1980
The authors had 75 patients with myocardial infarction under observation. After the 15th day of the disease various disorders of… Expand
1979
1979
1 The haemodynamic and electrocardiographic effects of intravenous disopyramide were studied in fifteen patients with acute… Expand
Highly Cited
1978
Highly Cited
1978
1 Serum, urine and pharmacologic effect (prolongation of the QT interval) kinetics of the antiarrhythmic disopyramide have been… Expand
1973
1973
  • Drug and therapeutics bulletin
  • 1973
  • Corpus ID: 40900274
Disopyramide (Rythmodan - Roussel) is an anti-arrhythmic drug for oral use which is being promoted as a ‘new cardio-specific for… Expand